Australia markets close in 18 minutes
  • ALL ORDS

    7,027.40
    +86.80 (+1.25%)
     
  • ASX 200

    6,773.20
    +99.90 (+1.50%)
     
  • AUD/USD

    0.7742
    +0.0030 (+0.39%)
     
  • OIL

    62.42
    +0.92 (+1.50%)
     
  • GOLD

    1,746.70
    +17.90 (+1.04%)
     
  • BTC-AUD

    59,672.51
    +818.52 (+1.39%)
     
  • CMC Crypto 200

    922.59
    -10.54 (-1.13%)
     
  • AUD/EUR

    0.6408
    +0.0025 (+0.39%)
     
  • AUD/NZD

    1.0653
    +0.0003 (+0.03%)
     
  • NZX 50

    12,301.81
    +74.52 (+0.61%)
     
  • NASDAQ

    12,909.44
    +81.14 (+0.63%)
     
  • FTSE

    6,483.43
    -168.53 (-2.53%)
     
  • Dow Jones

    30,932.37
    -469.63 (-1.50%)
     
  • DAX

    13,786.29
    -93.01 (-0.67%)
     
  • Hang Seng

    29,328.38
    +348.17 (+1.20%)
     
  • NIKKEI 225

    29,588.47
    +622.46 (+2.15%)
     

United States Non-Small Cell Lung Cancer Market and Competitive Landscape Report 2021

Research and Markets
·3-min read

Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Non-Small Cell Lung Cancer Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

US Non-Small Cell Lung Cancer Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Non-Small Cell Lung Cancer pipeline products, Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer market valuations and forecast, Non-Small Cell Lung Cancer drugs sales and competitive landscape in the US.

The research is classified into seven sections - Non-Small Cell Lung Cancer treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Non-Small Cell Lung Cancer pipeline: Find out the products in clinical trials for the treatment of Non-Small Cell Lung Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Non-Small Cell Lung Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Non-Small Cell Lung Cancer in the US

  • Non-Small Cell Lung Cancer drugs: Identify key products marketed and prescribed for Non-Small Cell Lung Cancer in the US, including trade name, molecule name, and company

  • Non-Small Cell Lung Cancer drugs sales: Find out the sales revenues of Non-Small Cell Lung Cancer drugs in the US

  • Non-Small Cell Lung Cancer market valuations: Find out the market size for Non-Small Cell Lung Cancer drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026

  • Non-Small Cell Lung Cancer drugs market share: Find out the market shares for key Non-Small Cell Lung Cancer drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Non-Small Cell Lung Cancer market analysis and sales trends

  • Track competitor drugs sales and market share in the US Non-Small Cell Lung Cancer market

  • Track competitive developments in Non-Small Cell Lung Cancer market and present key issues and learnings

  • Synthesize insights for Non-Small Cell Lung Cancer market and products to drive business performance

  • Answer key business questions about the Non-Small Cell Lung Cancer market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Non-Small Cell Lung Cancer products

  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1) Non-Small Cell Lung Cancer Treatments

2) Non-Small Cell Lung Cancer Pipeline

3) US Non-Small Cell Lung Cancer Epidemiology

4) Marketed Drugs for Non-Small Cell Lung Cancer in US

5) US Non-Small Cell Lung Cancer Market Size and Forecast

6) US Non-Small Cell Lung Cancer Products Sales and Forecast

7) US Non-Small Cell Lung Cancer Market Competitive Landscape

8) Methodology

For more information about this report visit https://www.researchandmarkets.com/r/v3zypc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900